Terns Pharmaceuticals
Anne Bonneville is an experienced toxicology executive with a solid track record in the pharmaceutical industry. Currently serving as the Executive Director of Toxicology at Terns Pharmaceuticals since May 2019, Anne has held various leadership roles, including Director of Toxicology at ChemoCentryx and multiple positions with a focus on toxicology at companies such as Medivation, Elan Pharmaceuticals, and Johnson & Johnson PRD. With a PhD in Pharmacology and Toxicology from the University of Arizona and a Bachelor of Science in Avian Sciences from the University of California, Davis, Anne has established a prominent reputation in the field over two decades, marked by expertise in both preclinical and clinical research.
This person is not in any teams
Terns Pharmaceuticals
An emerging global leader in the development of molecularly-targeted drugs and combination therapies to treat liver diseases and liver cancer.